SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2169325

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2169325

Next-Generation Sequencing Technologies Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 305 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 7295
Printable PDF & Excel (Enterprise License above 5 users)
USD 8495

Add to Cart

Description

Table of Contents

Introduction

Next-generation sequencing technologies read DNA and RNA at massive scale, allowing researchers and clinicians to analyse entire genomes, exomes, transcriptomes or targeted gene panels quickly and at steadily falling cost. These platforms, along with the reagents, consumables and services that support them, underpin cancer diagnostics, prenatal and reproductive testing, rare disease diagnosis, infectious disease surveillance, consumer genomics and basic biological research. In 2026, the market is valued at US$13.81 Bn and is projected to reach US$35.63 Bn by 2033, registering a CAGR of 14.50%. This strong growth reflects the movement of sequencing from research laboratories into routine clinical care. As the cost per genome declines and new high-throughput instruments arrive, testing becomes affordable for more patients and more applications. Clinical laboratories are becoming the main growth engine, and the technology base is diversifying, with long-read platforms and new chemistries complementing established short-read systems. At the same time, the field must manage challenges around data analysis, storage, interpretation, research funding and reimbursement.

Market Insights

The market is segmented by offering, technology, application and end user. Offerings include products, such as instruments, reagents and consumables, and services, such as sequencing and analysis provided by specialist laboratories. Technologies cover sequencing by synthesis, long-read sequencing, ion semiconductor sequencing and others. Applications span oncology, reproductive health, rare and inherited diseases, infectious diseases, consumer genomics and other uses. End users include academic and research institutes, hospitals and clinical laboratories, pharmaceutical and biotechnology companies, and others. Several trends stand out. Clinical laboratories are becoming the primary growth engine as sequencing-based tests move into routine care for cancer, pregnancy and inherited conditions. The market is also moving away from reliance on a single dominant technology toward a mix of short-read, long-read and newer chemistries, giving customers more choice in accuracy, read length, throughput and cost. Companies are broadening into adjacent fields as well, illustrated by a leading sequencing company's agreement in June 2025 to acquire a proteomics business and extend its multi-omics capabilities.

Drivers

The falling cost per genome and the arrival of new high-throughput platforms form the first high-impact driver over the medium term. Each new generation of instruments sequences more data per run at lower cost, making large studies and routine clinical tests economically viable. Lower costs expand the range of applications and bring sequencing within reach of smaller laboratories and health systems in more countries. The second high-impact driver, operating over the long term, is clinical adoption in oncology, rare diseases and reproductive health. Tumour profiling guides targeted cancer therapies, genome sequencing shortens the diagnostic journey for children with rare conditions, and non-invasive prenatal testing has become widespread. As clinical evidence and guidelines expand, test volumes increase steadily. Restraints shape the outlook. Data analysis, storage and interpretation burdens are a medium-impact, medium-term restraint, since sequencing generates enormous datasets that require skilled bioinformatics. Research funding cuts, trade tensions and reimbursement gaps are a medium-impact, short-term restraint, particularly in North America and Asia Pacific.

Business Opportunity

Long-read and multi-omics sequencing represent a premium technology revenue pool. Long-read platforms can resolve complex genomic regions, structural variants and repetitive sequences that short-read methods struggle to capture, which is valuable for rare disease diagnosis, cancer research and complete genome assembly. Multi-omics approaches combine genomic data with epigenetic, transcriptomic and protein information to provide a fuller picture of biology and disease. Suppliers offering these capabilities can command higher prices and attract research and clinical customers seeking deeper insights. A second opportunity lies in population genomics and precision medicine programmes, a large-volume revenue pool. Governments and health systems around the world are sequencing large numbers of citizens to build national genomic databases, improve disease understanding and guide personalised treatment. These programmes require sustained sequencing capacity, data infrastructure and analysis services over many years. Companies that can deliver high throughput at low cost, along with secure data management and interpretation tools, are well positioned to win these long-term national contracts.

Region Analysis

North America leads the market with a 42.5% share in 2026. The region benefits from a large base of research institutions, strong pharmaceutical and biotechnology industries, early clinical adoption of genomic testing and established reimbursement for many sequencing-based tests. However, research funding pressures present some short-term uncertainty. Asia Pacific is the fastest-growing region, expanding at 17.6% CAGR, supported by large population genomics initiatives, expanding healthcare investment, growing local instrument production and rising clinical demand in oncology and reproductive health. Europe is a significant market with national genomic medicine programmes, strong academic research and growing integration of sequencing into health systems, although its share is not specified. Latin America is a developing market, with adoption increasing through academic centres, private laboratories and expanding cancer and prenatal testing. The Middle East and Africa shows growing interest, particularly through national genome projects and investments in precision medicine in several Gulf countries. Across regions, cost, reimbursement and data capabilities will determine the pace of adoption.

Key Players

  • Illumina
  • Thermo Fisher Scientific
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • BGI Group (MGI Tech)

Segmentation

By Offering:

  • Products
  • Services

By Technology:

  • Sequencing by Synthesis
  • Long-read Sequencing
  • Ion Semiconductor Sequencing
  • Others

By Application:

  • Oncology
  • Reproductive Health
  • Rare & Inherited Diseases
  • Infectious Diseases
  • Consumer Genomics
  • Others

By End User:

  • Academic & Research Institutes
  • Hospitals & Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Next-Generation Sequencing Technologies Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Next-Generation Sequencing Technologies Market Outlook, 2020 - 2033

  • 3.1. Global Next-Generation Sequencing Technologies Market Outlook, by Offering, Value (US$ Bn), 2020-2033
    • 3.1.1. Products
    • 3.1.2. Services
  • 3.2. Global Next-Generation Sequencing Technologies Market Outlook, by Technology, Value (US$ Bn), 2020-2033
    • 3.2.1. Sequencing by Synthesis
    • 3.2.2. Long-read Sequencing
    • 3.2.3. Ion Semiconductor Sequencing
    • 3.2.4. Others
  • 3.3. Global Next-Generation Sequencing Technologies Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.3.1. Oncology
    • 3.3.2. Reproductive Health
    • 3.3.3. Rare & Inherited Diseases
    • 3.3.4. Infectious Diseases
    • 3.3.5. Consumer Genomics
    • 3.3.6. Others
  • 3.4. Global Next-Generation Sequencing Technologies Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.4.1. Academic & Research Institutes
    • 3.4.2. Hospitals & Clinical Laboratories
    • 3.4.3. Pharmaceutical & Biotechnology Companies
    • 3.4.4. Others
  • 3.5. Global Next-Generation Sequencing Technologies Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America Next-Generation Sequencing Technologies Market Outlook, 2020 - 2033

  • 4.1. North America Next-Generation Sequencing Technologies Market Outlook, by Offering, Value (US$ Bn), 2020-2033
    • 4.1.1. Products
    • 4.1.2. Services
  • 4.2. North America Next-Generation Sequencing Technologies Market Outlook, by Technology, Value (US$ Bn), 2020-2033
    • 4.2.1. Sequencing by Synthesis
    • 4.2.2. Long-read Sequencing
    • 4.2.3. Ion Semiconductor Sequencing
    • 4.2.4. Others
  • 4.3. North America Next-Generation Sequencing Technologies Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.3.1. Oncology
    • 4.3.2. Reproductive Health
    • 4.3.3. Rare & Inherited Diseases
    • 4.3.4. Infectious Diseases
    • 4.3.5. Consumer Genomics
    • 4.3.6. Others
  • 4.4. North America Next-Generation Sequencing Technologies Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.4.1. Academic & Research Institutes
    • 4.4.2. Hospitals & Clinical Laboratories
    • 4.4.3. Pharmaceutical & Biotechnology Companies
    • 4.4.4. Others
  • 4.5. North America Next-Generation Sequencing Technologies Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.5.1. U.S. Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 4.5.2. U.S. Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 4.5.3. U.S. Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 4.5.4. U.S. Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 4.5.5. Canada Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 4.5.6. Canada Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 4.5.7. Canada Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 4.5.8. Canada Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Next-Generation Sequencing Technologies Market Outlook, 2020 - 2033

  • 5.1. Europe Next-Generation Sequencing Technologies Market Outlook, by Offering, Value (US$ Bn), 2020-2033
    • 5.1.1. Products
    • 5.1.2. Services
  • 5.2. Europe Next-Generation Sequencing Technologies Market Outlook, by Technology, Value (US$ Bn), 2020-2033
    • 5.2.1. Sequencing by Synthesis
    • 5.2.2. Long-read Sequencing
    • 5.2.3. Ion Semiconductor Sequencing
    • 5.2.4. Others
  • 5.3. Europe Next-Generation Sequencing Technologies Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.3.1. Oncology
    • 5.3.2. Reproductive Health
    • 5.3.3. Rare & Inherited Diseases
    • 5.3.4. Infectious Diseases
    • 5.3.5. Consumer Genomics
    • 5.3.6. Others
  • 5.4. Europe Next-Generation Sequencing Technologies Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.4.1. Academic & Research Institutes
    • 5.4.2. Hospitals & Clinical Laboratories
    • 5.4.3. Pharmaceutical & Biotechnology Companies
    • 5.4.4. Others
  • 5.5. Europe Next-Generation Sequencing Technologies Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.5.1. Germany Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 5.5.2. Germany Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 5.5.3. Germany Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 5.5.4. Germany Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 5.5.5. Italy Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 5.5.6. Italy Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 5.5.7. Italy Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 5.5.8. Italy Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 5.5.9. France Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 5.5.10. France Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 5.5.11. France Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 5.5.12. France Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 5.5.13. U.K. Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 5.5.14. U.K. Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 5.5.15. U.K. Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 5.5.16. U.K. Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 5.5.17. Spain Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 5.5.18. Spain Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 5.5.19. Spain Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 5.5.20. Spain Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 5.5.21. Russia Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 5.5.22. Russia Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 5.5.23. Russia Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 5.5.24. Russia Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 5.5.25. Rest of Europe Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 5.5.26. Rest of Europe Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 5.5.27. Rest of Europe Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 5.5.28. Rest of Europe Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Next-Generation Sequencing Technologies Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Next-Generation Sequencing Technologies Market Outlook, by Offering, Value (US$ Bn), 2020-2033
    • 6.1.1. Products
    • 6.1.2. Services
  • 6.2. Asia Pacific Next-Generation Sequencing Technologies Market Outlook, by Technology, Value (US$ Bn), 2020-2033
    • 6.2.1. Sequencing by Synthesis
    • 6.2.2. Long-read Sequencing
    • 6.2.3. Ion Semiconductor Sequencing
    • 6.2.4. Others
  • 6.3. Asia Pacific Next-Generation Sequencing Technologies Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.3.1. Oncology
    • 6.3.2. Reproductive Health
    • 6.3.3. Rare & Inherited Diseases
    • 6.3.4. Infectious Diseases
    • 6.3.5. Consumer Genomics
    • 6.3.6. Others
  • 6.4. Asia Pacific Next-Generation Sequencing Technologies Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.4.1. Academic & Research Institutes
    • 6.4.2. Hospitals & Clinical Laboratories
    • 6.4.3. Pharmaceutical & Biotechnology Companies
    • 6.4.4. Others
  • 6.5. Asia Pacific Next-Generation Sequencing Technologies Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.5.1. China Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 6.5.2. China Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 6.5.3. China Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 6.5.4. China Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 6.5.5. Japan Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 6.5.6. Japan Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 6.5.7. Japan Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 6.5.8. Japan Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 6.5.9. South Korea Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 6.5.10. South Korea Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 6.5.11. South Korea Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 6.5.12. South Korea Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 6.5.13. India Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 6.5.14. India Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 6.5.15. India Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 6.5.16. India Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 6.5.17. Southeast Asia Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 6.5.18. Southeast Asia Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 6.5.19. Southeast Asia Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 6.5.20. Southeast Asia Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 6.5.21. Rest of SAO Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 6.5.22. Rest of SAO Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 6.5.23. Rest of SAO Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 6.5.24. Rest of SAO Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Next-Generation Sequencing Technologies Market Outlook, 2020 - 2033

  • 7.1. Latin America Next-Generation Sequencing Technologies Market Outlook, by Offering, Value (US$ Bn), 2020-2033
    • 7.1.1. Products
    • 7.1.2. Services
  • 7.2. Latin America Next-Generation Sequencing Technologies Market Outlook, by Technology, Value (US$ Bn), 2020-2033
    • 7.2.1. Sequencing by Synthesis
    • 7.2.2. Long-read Sequencing
    • 7.2.3. Ion Semiconductor Sequencing
    • 7.2.4. Others
  • 7.3. Latin America Next-Generation Sequencing Technologies Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.3.1. Oncology
    • 7.3.2. Reproductive Health
    • 7.3.3. Rare & Inherited Diseases
    • 7.3.4. Infectious Diseases
    • 7.3.5. Consumer Genomics
    • 7.3.6. Others
  • 7.4. Latin America Next-Generation Sequencing Technologies Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.4.1. Academic & Research Institutes
    • 7.4.2. Hospitals & Clinical Laboratories
    • 7.4.3. Pharmaceutical & Biotechnology Companies
    • 7.4.4. Others
  • 7.5. Latin America Next-Generation Sequencing Technologies Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.5.1. Brazil Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 7.5.2. Brazil Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 7.5.3. Brazil Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 7.5.4. Brazil Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 7.5.5. Mexico Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 7.5.6. Mexico Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 7.5.7. Mexico Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 7.5.8. Mexico Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 7.5.9. Argentina Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 7.5.10. Argentina Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 7.5.11. Argentina Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 7.5.12. Argentina Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 7.5.13. Rest of LATAM Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 7.5.14. Rest of LATAM Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 7.5.15. Rest of LATAM Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 7.5.16. Rest of LATAM Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Next-Generation Sequencing Technologies Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Next-Generation Sequencing Technologies Market Outlook, by Offering, Value (US$ Bn), 2020-2033
    • 8.1.1. Products
    • 8.1.2. Services
  • 8.2. Middle East & Africa Next-Generation Sequencing Technologies Market Outlook, by Technology, Value (US$ Bn), 2020-2033
    • 8.2.1. Sequencing by Synthesis
    • 8.2.2. Long-read Sequencing
    • 8.2.3. Ion Semiconductor Sequencing
    • 8.2.4. Others
  • 8.3. Middle East & Africa Next-Generation Sequencing Technologies Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.3.1. Oncology
    • 8.3.2. Reproductive Health
    • 8.3.3. Rare & Inherited Diseases
    • 8.3.4. Infectious Diseases
    • 8.3.5. Consumer Genomics
    • 8.3.6. Others
  • 8.4. Middle East & Africa Next-Generation Sequencing Technologies Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.4.1. Academic & Research Institutes
    • 8.4.2. Hospitals & Clinical Laboratories
    • 8.4.3. Pharmaceutical & Biotechnology Companies
    • 8.4.4. Others
  • 8.5. Middle East & Africa Next-Generation Sequencing Technologies Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.5.1. GCC Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 8.5.2. GCC Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 8.5.3. GCC Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 8.5.4. GCC Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 8.5.5. South Africa Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 8.5.6. South Africa Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 8.5.7. South Africa Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 8.5.8. South Africa Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 8.5.9. Egypt Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 8.5.10. Egypt Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 8.5.11. Egypt Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 8.5.12. Egypt Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 8.5.13. Nigeria Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 8.5.14. Nigeria Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 8.5.15. Nigeria Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 8.5.16. Nigeria Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
    • 8.5.17. Rest of Middle East Next-Generation Sequencing Technologies Market Outlook, by Offering, 2020-2033
    • 8.5.18. Rest of Middle East Next-Generation Sequencing Technologies Market Outlook, by Technology, 2020-2033
    • 8.5.19. Rest of Middle East Next-Generation Sequencing Technologies Market Outlook, by Application, 2020-2033
    • 8.5.20. Rest of Middle East Next-Generation Sequencing Technologies Market Outlook, by End User, 2020-2033
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Illumina
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Thermo Fisher Scientific
    • 9.4.3. Pacific Biosciences
    • 9.4.4. Oxford Nanopore Technologies
    • 9.4.5. BGI Group (MGI Tech)

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!